Intralymphocyte free magnesium in a group of subjects with essential hypertension

Hypertension

Volumn 28, Issue 3, 1996, Pages 433-439

  Delva, Pietro T ^a   Pastori, Caterina ^a   Degan, Maurizio ^a   Montesi, Germana D ^a   Lechi, Alessandro ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

calcium; hypertension, arterial; lymphocytes; magnesium; triglycerides

Indexed keywords

CALCIUM ION; MAGNESIUM ION; RENIN; SODIUM ION; TRIACYLGLYCEROL;

ADULT; ARTICLE; CALCIUM CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE METABOLISM; HUMAN; LIPID METABOLISM; LYMPHOCYTE; MAGNESIUM METABOLISM; MALE; PRIORITY JOURNAL; SODIUM EXCRETION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029793017     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.3.433     Document Type: Article

References (39)

1. 2+ and vascular contractility. Miner Electrolyte Metab. 1993;19:323-336.
2. Joffres MR, Reed DM, Yano K. Relationship of magnesium intake and other dietary factors to blood pressure: the Honolulu Heart Study. Am J Clin Nutr. 1987;45:469-475.
3. Cappuccio FP, Markandu ND, Beynon GW, Shore AC, Sampson B, MacGregor GA. Lack of effect of oral magnesium on high blood pressure: a double blind study. Br Med J. 1985;291:235-238.
4. Henderson DG, Schierue J, Schudt J. Effect of magnesium supplementation on blood pressure and electrolyte concentrations in hypertensive patients receiving long-term diuretic treatment. Br Med J. 1986;293:664-665.
5. Nowson CA, Morgan TO. Magnesium supplementation in mild hypertensive patients on a moderately low sodium diet. Clin Exp Pharmacol Toxicol. 1989;16:299-302.
6. Johnson CJ, Peterson DR, Smith EK. Myocardial tissue concentrations of magnesium and potassium in men dying suddenly from ischemic heart disease. Am J Clin Nutr. 1979;32:967-970.
7. Albert DG, Morita Y, Iseri LT. Serum magnesium and plasma sodium levels in essential vascular hypertension. Circulation. 1958;17:761-764.
8. Veniero JC, Gupta RK. NMR measurements of intracellular ions in living systems. Annu Rep NMR Spect. 1992;24:219-266.
9. Raju B, Murphy E, Levy LA, Hall RD, London RE. A fluorescent indicator for measuring cytosolic free magnesium. Am J Physiol. 1989;256:C540-C548.
10. 2+ using mag-fura-2. Am J Physiol. 1992;263:C300-C307.
11. Sheehan J, White A. Diuretic-associated hypomagnesemia. Br Med J. 1982;285:1157-1159.
12. Wathen LK, Wuorala KW, Wathen MW. Validation of an immunoradiometric assay to measure plasma levels of active renin. J Clin Lab Anal. 1991;5:284-292.
13. Ng LL, Davies JE, Garrido MC. Intracellular free magnesium in human lymphocytes and the response to lectins. Clin Sci. 1991;80:539-547.
14. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
15. London RE. Methods for measurement of intracellular magnesium: NMR and fluorescence. Annu Rev Physiol. 1991;53:241-258.
16. Paolisso G, Passariello NS, Torecca R, Buoninconti R, Varricchio M, D'Onorio F. Impaired insulin-mediated erythrocyte magnesium accumulation in essential hypertension. Clin Sci. 1987;73:535-539.
17. Touyz RM, Milne FJ, Seftel HC, Reinach SG. Magnesium, calcium, sodium and potassium status in normotensive and hypertensive Johannesburg residents. S Afr Med J. 1987;72:377-381.
18. Resnick LM, Gupta RK, Laragh JH. Intracellular free magnesium in erythrocytes of essential hypertension: relation to blood pressure and serum divalent cations. Proc Natl Acad Sci USA. 1984;81:6511-6515.
19. 31P-nuclear magnetic resonance measurement of free erythrocyte magnesium concentration in man and its relation to blood pressure. Clin Sci. 1988;74:513-517.
20. Lindner A, Kenny M, Meacham AJ. Effects of a circulating factor in patients with essential hypertension on intracellular free calcium in normal platelets. N Engl J Med. 1987;316:509-513.
21. Wright GL, Rogerson ME, McCumbee WD. Stimulation of aortic tissue calcium uptake by an extract of spontaneously hypertensive rat erythrocytes possessing hypertensive properties. Can J Physiol Pharmacol. 1986;64:1515-1520.
22. Tsien RY, Pozzan T, Rink TJ. Calcium homeostasis in intact lymphocytes: cytosolic free calcium monitored with a new intracellular trapped fluorescent indicator. J Cell Biol. 1982;94:325-334.
23. Zidek W, Knorr M, Losse H, Baumgart P, Vetter H. Sodium and calcium in lymphocytes and erythrocytes in essential hypertension. J Hypertens. 1983;1(suppl 2):3-5.
24. Erne P, Bolli P, Burgisser E, Buhler FR. Correlation of platelet calcium with blood pressure: effect of antihypertensive therapy. N Engl J Med. 1984;310:1084-1088.
25. Bing RF, Heagerty AM, Jackson JA, Thurston H, Swales JD. Leukocyte ionized calcium and sodium content and blood pressure in humans. Hypertension. 1986;8:483-488.
26. Shore AC, Beynon GW, Jones JC, Markandu ND, Sagnella GA, MacGregor GA. Mononuclear intracellular free calcium: does it correlate with blood pressure? J Hypertext. 1985;3:183-187.
27. Resnick LM, Gupta RK, Gruenspan HL, Laragh JH. Intracellular free magnesium in hypertension: relation to peripheral insulin resistance. J Hypertens. 1988;6(suppl 4):S199-S201.
28. Mather HM, Nishet JA, Burton GH, Poston G, Bland JM, Bailey PA, Pilkington TR. Hypomagnesemia in diabetes. Clin Chim Acta. 1979;95:235-242.
29. Sjogren A, Floren CH, Nilsson A. Magnesium deficiency in IDDM related to level of glycosylated hemoglobin. Diabetes. 1986;35:459-463.
30. Paolisso G, Scheen A, Cozzolino D, Di Maro G, Varricchio M, D'Onofrio F, Lefebvre PJ. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab. 1994:78:1510-1514.
31. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1495-1507.
32. Larsson B, Welin L, Eriksson H. The plurimetabolic syndrome and the study of men born in 1913, Goteborg, Sweden. In: Crepaldi G, Tiengo A, Manzato E, eds. Diabetes, Obesity and Hyperlipemias: The Plurimetabolic Syndrome. Amsterdam, Netherlands: Elsevier Science Publishers; 1993:17-24.
33. Woods KL, Fletcher S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1992;339:1553-1558.
34. Resnick LM. Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders. Am J Med. 1992;93(suppl 2A):2a-20s.
35. Resnick LM, Gupta RK, Bhargava KK, Gruenspan H, Alderman MH, Laragh JH. Cellular ions in hypertension, diabetes, and obesity: a nuclear magnetic resonance spectroscopic study. Hypertension. 1991;17:951-957.
36. Resnick L, Laragh J, Sealey J, Alderman M, Divalent cations in essential hypertension: relations between serum ionized calcium, magnesium, and plasma renin activity. N Engl J Med. 1983;309:888-891.
37. Rayssiguier Y. Magnesium and lipids in cardiovascular disease. J Am Coll Nutr. 1986;5:507-519.
38. Rasmussen HS, Aurup P, Goldstein K, McNair P. Mortensen PB, Larsen OG, Lawaetz H. Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. Arch Intern Med. 1989;149:1050-1053.
39. Altura BT, Brust M, Sherman B, Barbour RL, Stempak JG, Altura M. Magnesium dietary intake modulates blood lipid levels and atherogenesis. Proc Natl Acad Sci USA. 1990;87:1840-1844.